The MALAT1/hsa-miR-1-3p/BRF2/LKB1/AMPK regulatory axis plays a crucial role in HCC progression and represents potential therapeutic targets for HCC (Fig. 8f). This evidence concerns the gene BRF2 and hepatocellular carcinoma.